{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:53:14Z","timestamp":1777668794438,"version":"3.51.4"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>More and more studies have shown that the intestinal microbiota is the main factor in the pathogenesis of type 1 diabetes mellitus (T1DM). Beta cell expansion factor A (BefA) is a protein expressed by intestinal microorganisms. It has been proven to promote the proliferation of \u03b2-cells and has broad application prospects. However, as an intestinal protein, there have not been studies and reports on its application in diabetes and its mechanism of action. In this study, a T1DM model induced by multiple low-dose STZ (MLD-STZ) injections was established, and BefA protein was administered to explore its therapeutic effect in T1DM and the potential mechanism of intestinal microbiota. BefA protein significantly reduced the blood glucose, maintained the body weight, and improved the glucose tolerance of the mice. At the same time, the BefA protein significantly increased the expression of ZO-1, Occludin, and significantly reduced the expression of TLR-4, Myd88, and p-p65\/p65. BefA protein significantly reduced the relative expression of pro-inflammatory cytokines IL-1\u03b2, IL-6 and TNF-\u03b1. In addition, our high-throughput sequencing shows for the first time that the good hypoglycemic effect of BefA protein is strongly related to the increase in the abundance of the beneficial gut bacteria <jats:italic>Lactobacillus<\/jats:italic>, <jats:italic>Bifidobacterium<\/jats:italic> and <jats:italic>Oscillospria<\/jats:italic> and the decrease in the abundance of the opportunistic pathogen <jats:italic>Acinetobacter<\/jats:italic>. Our group used animal models to verify the hypoglycemic effect of BefA protein, and first explored the potential mechanism of intestinal microbiota in BefA protein treatment.<\/jats:p>","DOI":"10.3389\/fcimb.2021.719542","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T06:11:19Z","timestamp":1631859079000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Intestinal Microbiota Play an Important Role in the Treatment of Type I Diabetes in Mice With BefA Protein"],"prefix":"10.3389","volume":"11","author":[{"given":"Qi","family":"Qin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuyin","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingtao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"530","DOI":"10.4158\/EP.9.6.530","article-title":"Nocturnal Hypoglycemia: Clinical Manifestations and Therapeutic Strategies Toward Prevention","volume":"9","author":"Allen","year":"2003","journal-title":"Endocr. Pract."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.2169\/internalmedicine.49.3218","article-title":"Comparison of Adverse Gastrointestinal Effects of Acarbose and Miglitol in Healthy Men: A Crossover Study","volume":"49","author":"Aoki","year":"2010","journal-title":"Intern. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0140-6736(01)05415-0","article-title":"Type 1 Diabetes: New Perspectives on Disease Pathogenesis and Treatment","volume":"358","author":"Atkinson","year":"2001","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/S0140-6736(19)31142-0","article-title":"Advances in Technology for Management of Type 1 Diabetes","volume":"394","author":"Beck","year":"2019","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"10713","DOI":"10.1073\/pnas.1711235114","article-title":"Gut Bacteria From Multiple Sclerosis Patients Modulate Human T Cells and Exacerbate Symptoms in Mouse Models","volume":"114","author":"Cekanaviciute","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.\u00a0S.\u00a0A."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0126-x","article-title":"Mechanisms Regulating Intestinal Barrier Integrity and its Pathological Implications","volume":"50","author":"Chelakkot","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jphs.2020.02.009","article-title":"Tong-Fu-Li-Fei Decoction Exerts a Protective Effect on Intestinal Barrier of Sepsis in Rats Through Upregulating ZO-1\/Occludin\/Claudin-1 Expression","volume":"143","author":"Chen","year":"2020","journal-title":"J. Pharmacol. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF Diabetes Atlas: Global Estimates of Diabetes Prevalence for 2017 and Projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-9882-1_1","article-title":"Sixty Years of Drug Discovery for Type 2 Diabetes: Where Are We Now","volume":"2076","author":"Clapham","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"j1321","DOI":"10.1136\/bmj.j1321","article-title":"Pancreas Transplantation","volume":"357","author":"Dean","year":"2017","journal-title":"Bmj"},{"key":"B12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.metabol.2015.10.014","article-title":"Metformin-Associated Lactic Acidosis: Current Perspectives on Causes and Risk","volume":"65","author":"Defronzo","year":"2016","journal-title":"Metabolism"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.2522\/ptj.20080020","article-title":"Epidemiology of Diabetes and Diabetes-Related Complications","volume":"88","author":"Deshpande","year":"2008","journal-title":"Phys. Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"6458","DOI":"10.1073\/pnas.1720017115","article-title":"Gut Microbiota Regulates Maturation of the Adult Enteric Nervous System via Enteric Serotonin Networks","volume":"115","author":"De Vadder","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 Diabetes","volume":"391","author":"Dimeglio","year":"2018","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0140-6736(16)32567-3","article-title":"Home Use of a Bihormonal Bionic Pancreas Versus Insulin Pump Therapy in Adults With Type 1 Diabetes: A Multicentre Randomised Crossover Trial","volume":"389","author":"El-Khatib","year":"2017","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/s41467-017-01682-2","article-title":"Analyses of Gut Microbiota and Plasma Bile Acids Enable Stratification of Patients for Antidiabetic Treatment","volume":"8","author":"Gu","year":"2017","journal-title":"Nat. Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/S1262-3636(14)72693-X","article-title":"Adverse Effects and Safety of SGLT-2 Inhibitors","volume":"40","author":"Halimi","year":"2014","journal-title":"Diabetes Metab."},{"key":"B18","doi-asserted-by":"publisher","first-page":"16180","DOI":"10.1038\/nmicrobiol.2016.180","article-title":"Integrated Multi-Omics of the Human Gut Microbiome in a Case Study of Familial Type 1 Diabetes","volume":"2","author":"Heintz-Buschart","year":"2016","journal-title":"Nat. Microbiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e20145","DOI":"10.7554\/eLife.20145","article-title":"A Conserved Bacterial Protein Induces Pancreatic Beta Cell Expansion During Zebrafish Development","volume":"5","author":"Hill","year":"2016","journal-title":"Elife"},{"key":"B20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13099-020-0346-1","article-title":"Gut Microbiota Changes in Children With Autism Spectrum Disorder: A Systematic Review","volume":"12","author":"Ho","year":"2020","journal-title":"Gut Pathog."},{"key":"B21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1517\/14740338.5.1.131","article-title":"Safety and Side Effects of the Insulin Analogues","volume":"5","author":"Kamal","year":"2006","journal-title":"Expert Opin. Drug Saf."},{"key":"B22","doi-asserted-by":"publisher","first-page":"17016","DOI":"10.1038\/nrdp.2017.16","article-title":"Type 1 Diabetes Mellitus","volume":"3","author":"Katsarou","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B23","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.tim.2016.02.015","article-title":"Oscillospira: A Central, Enigmatic Component of the Human Gut Microbiota","volume":"24","author":"Konikoff","year":"2016","journal-title":"Trends Microbiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1517\/14740338.2012.691963","article-title":"Thiazolidinedione Safety","volume":"11","author":"Kung","year":"2012","journal-title":"Expert Opin. Drug Saf."},{"key":"B25","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1053\/j.gastro.2016.07.008","article-title":"Inflammation and the Intestinal Barrier: Leukocyte-Epithelial Cell Interactions, Cell Junction Remodeling, and Mucosal Repair","volume":"151","author":"Luissint","year":"2016","journal-title":"Gastroenterology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000459641","article-title":"The Burden of Diabetes: Emerging Data","volume":"60","author":"Maffi","year":"2017","journal-title":"Dev. Ophthalmol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s00125-015-3844-9","article-title":"Metformin and the Gastrointestinal Tract","volume":"59","author":"Mccreight","year":"2016","journal-title":"Diabetologia"},{"key":"B28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.4155\/fmc.13.13","article-title":"Antidiabetic Agents: Past, Present and Future","volume":"5","author":"Mehanna","year":"2013","journal-title":"Future Med. Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.cmet.2018.06.012","article-title":"Gut Microbiota-Stimulated Innate Lymphoid Cells Support \u03b2-Defensin 14 Expression in Pancreatic Endocrine Cells, Preventing Autoimmune Diabetes","volume":"28","author":"Miani","year":"2018","journal-title":"Cell Metab."},{"key":"B30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11892-016-0781-z","article-title":"The Role of the Intestinal Microbiome in Type 1 Diabetes Pathogenesis","volume":"16","author":"Needell","year":"2016","journal-title":"Curr. Diabetes Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s13300-019-0563-0","article-title":"Epidemiology, Quality of Life, and Costs Associated With Hypoglycemia in Patients With Diabetes in Spain: A Systematic Literature Review","volume":"10","author":"N\u00fa\u00f1ez","year":"2019","journal-title":"Diabetes Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","article-title":"Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes","volume":"178","author":"Riquelme","year":"2019","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results From the International Diabetes Federation Diabetes Atlas, 9(Th) Edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B34","doi-asserted-by":"publisher","first-page":"256707","DOI":"10.1155\/2012\/256707","article-title":"Animal Models of Diabetes Mellitus for Islet Transplantation","volume":"2012","author":"Sakata","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nrendo.2016.178","article-title":"Clinical Pancreatic Islet Transplantation","volume":"13","author":"Shapiro","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1007\/s00394-017-1481-4","article-title":"Amelioration of Obesity-Related Characteristics by a Probiotic Formulation in a High-Fat Diet-Induced Obese Rat Model","volume":"57","author":"Shin","year":"2018","journal-title":"Eur. J. Nutr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1053\/j.gastro.2018.09.008","article-title":"Manipulating the Gut Microbiome as a Treatment Strategy for Functional Gastrointestinal Disorders","volume":"155","author":"Simr\u00e9n","year":"2018","journal-title":"Gastroenterology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"972","DOI":"10.3390\/ijms21030972","article-title":"The Integral Role of Tight Junction Proteins in the Repair of Injured Intestinal Epithelium","volume":"21","author":"Slifer","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41577-019-0198-4","article-title":"The Intestinal Microbiota Fuelling Metabolic Inflammation","volume":"20","author":"Tilg","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s13300-018-0496-z","article-title":"Metabolic Control in Type 1 Diabetes: Is Adjunctive Therapy the Way Forward","volume":"9","author":"Warnes","year":"2018","journal-title":"Diabetes Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cmet.2019.11.017","article-title":"New Frontiers in the Treatment of Type 1 Diabetes","volume":"31","author":"Warshauer","year":"2020","journal-title":"Cell Metab."},{"key":"B42","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S2213-8587(17)30167-5","article-title":"Effect of Artificial Pancreas Systems on Glycaemic Control in Patients With Type 1 Diabetes: A Systematic Review and Meta-Analysis of Outpatient Randomised Controlled Trials","volume":"5","author":"Weisman","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B43","first-page":"139","article-title":"Mesenchymal Stem Cell-Based Therapy for Type 1 Diabetes","volume":"17","author":"Wu","year":"2014","journal-title":"Discovery Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e3043","DOI":"10.1002\/dmrr.3043","article-title":"Gut Microbiome in Type 1 Diabetes: A Comprehensive Review","volume":"34","author":"Zheng","year":"2018","journal-title":"Diabetes Metab. Res. Rev."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2021.719542\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T06:11:27Z","timestamp":1631859087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2021.719542\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":44,"alternative-id":["10.3389\/fcimb.2021.719542"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2021.719542","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,17]]},"article-number":"719542"}}